New drug targets 'Undruggable' cancer mutation in first human trial

NCT ID NCT05382559

Summary

This is a first-in-human study to find a safe dose of a new drug, ASP3082, for people with advanced solid tumors that have a specific genetic change called KRAS G12D. The study will test ASP3082 alone and in combination with other cancer drugs in up to 681 participants. The main goal is to understand the side effects and determine the best dose for future research.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, Beijing Municipality, China

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Cancer Institute Hospital of JFCR

    RECRUITING

    Koto-ku, Tokyo, Japan

  • Case Western

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • City of Hope National Medical Center

    RECRUITING

    Duarte, California, 91010, United States

  • Columbia University - Herbert Irving Comprehensive Cancer Center

    RECRUITING

    New York, New York, 10032, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Denver HealthONE Drug Development Unit

    RECRUITING

    Denver, Colorado, 80218, United States

  • Florida Cancer Specialist

    RECRUITING

    Lake Mary, Florida, 32746, United States

  • Florida Cancer Specialists & Research Institute Sarasota

    RECRUITING

    Sarasota, Florida, 34232-6422, United States

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Xuhui District, Shanghai Municipality, China

  • Georgetown University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

  • Hokkaido University Hospital

    RECRUITING

    Sapporo, Hokkaido, Japan

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Kindai University Hospital

    RECRUITING

    Sayama, Osaka, Japan

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • NEXT Oncology

    RECRUITING

    San Antonio, Texas, 78229, United States

  • NEXT Oncology - Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • National Cancer Center Hospital

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, Japan

  • Oregon Health and Science University

    RECRUITING

    Portland, Oregon, 97239, United States

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, Japan

  • PanOncology Trials

    RECRUITING

    San Juan, 00935, Puerto Rico

  • Roswell Park Cancer Institute

    RECRUITING

    Buffalo, New York, 14263, United States

  • SCRI Oncology Partners

    TERMINATED

    Nashville, Tennessee, 37203, United States

  • Shikoku Cancer Center

    RECRUITING

    Matsuyama, Ehime, Japan

  • Shizuoka Cancer Center

    RECRUITING

    Sunto-gun, Shizuoka, Japan

  • Site ES34001

    RECRUITING

    Barcelona, Spain

  • Site ES34002

    RECRUITING

    Málaga, Spain

  • Site ES34003

    RECRUITING

    Seville, Spain

  • Site ES34004

    RECRUITING

    Madrid, Spain

  • Site FR33001

    RECRUITING

    Lyon, France

  • Site FR33002

    RECRUITING

    Bordeaux, France

  • Site FR33003

    RECRUITING

    La Tronche, Grenobele, France

  • Site FR33004

    RECRUITING

    Villejuif, Île-de-France Region, France

  • Site FR33005

    RECRUITING

    Lyon, France

  • Site KR82001

    RECRUITING

    Jongno -Gu, Seoul, South Korea

  • Site KR82002

    RECRUITING

    Seongnam-si, Gyeonggi-do, South Korea

  • Site KR82003

    RECRUITING

    Seodaemun-gu, Seoul, South Korea

  • Site KR82004

    RECRUITING

    Songpa-gu, Seoul, South Korea

  • Smilow Cancer Center at Yale New Haven Hospital

    RECRUITING

    New Haven, Connecticut, 06520-8028, United States

  • Tohoku University Hospital

    RECRUITING

    Sendai, Miyagi, Japan

  • UCLA Santa Monica Hematology Oncology

    RECRUITING

    Santa Monica, California, 90404, United States

  • University of Florida, Davis Cancer Center

    RECRUITING

    Gainesville, Florida, 32610, United States

  • University of Kansas Medical Center

    RECRUITING

    Westwood, Kansas, 66205, United States

  • University of Wisconsin Hospital

    RECRUITING

    Madison, Wisconsin, 53792, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Yamaguchi University Hospital

    RECRUITING

    Ube, Yamaguchi, Japan

Conditions

Explore the condition pages connected to this study.